# SEVELAMER CARBONATE
> **ANDA207291** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2024-04-25
## Drug
- **FDA Application Number:** ANDA207291
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SEVELAMER CARBONATE
- **Generic name:** SEVELAMER CARBONATE
- **Active ingredients:** SEVELAMER CARBONATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2024-04-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207291)
---
*AI Analytics · CC0 1.0*